HomeInsightsResults

Thyrocare Technologies Ltd Quarterly Result

Thyrocare Technologies Ltd Quarterly Result

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

4.6 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Thyrocare Technologies Ltd

NSE: THYROCARE

Net Profit

₹ 26.42

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Thyrocare Technologies Ltd for the Sep '24 is ₹ 179.97 crore as compare to the Jun '24 revenue of ₹ 160.52 crore. This represent the growth of 12.116868%.
  • The ebitda of Thyrocare Technologies Ltd for the Sep '24 is ₹ 50.61 crore as compare to the Jun '24 ebitda of ₹ 45.9 crore. This represent the growth of 10.2614355%.
  • The net profit of Thyrocare Technologies Ltd for the Sep '24 is ₹ 26.42 crore as compare to the Jun '24 net profit of ₹ 23.94 crore. This represent the growth of 10.359229%.

Results Analysis

Market Price of Thyrocare Technologies Ltd

1M

1Y

3Y

5Y

Monitoring Thyrocare Technologies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024957.45
21 Nov 2024970.35
19 Nov 2024964.7
18 Nov 2024982.95
14 Nov 2024976.4
13 Nov 2024947.85
12 Nov 2024961.9
11 Nov 2024984.4
08 Nov 2024980.05
07 Nov 2024966.45

Historical Revenue of Thyrocare Technologies Ltd

No data available

* All values are in crore

Historical EBITDA of Thyrocare Technologies Ltd

No data available

* All values are in crore

Historical Net Profit of Thyrocare Technologies Ltd

No data available

* All values are in crore

Thyrocare Technologies Ltd News Hub

News

Thyrocare Tech hits 52 week high as Q2 PAT jumps 31% YoY to Rs 27 cr

Revenue from operations grew by 19.99% year on year (YoY) to Rs 177.36 crore in the quarte...

Read more

24 Oct 202411:15

News

Thyrocare Technologies schedules board meeting

Thyrocare Technologies will hold a meeting of the Board of Directors of the Company on 23 ...

Read more

17 Oct 202413:42

News

Thyrocare Technologies announces cessation of director

Thyrocare Technologies announced the cessation of Neetin Shivajirao Desai (DIN No: 0262236...

Read more

19 Sep 202414:29

News

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Thyrocare Technologies has signed a Business Transfer Agreement for purchase of the diagno...

Read more

30 Aug 202412:17

News

Thyrocare Tech to acquire diagnostic and pathological services of Vimta Lab

Thyrocare Technologies said that it shall have access to 11 centres of Vimta Labs at the l...

Read more

30 Aug 202414:30

News

Thyrocare Technologies AGM scheduled

Thyrocare Technologies announced that the Annual General Meeting (AGM) of the company will...

Read more

06 Aug 202417:18

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Thyrocare Technologies Ltd Quarterly Result

What is the EPS of Thyrocare Technologies Ltd stock?

The Earnings Per Share (EPS) of Thyrocare Technologies Ltd is 15.85. An EPS is the amount of net income attributed to each share of a common stock.

How is Thyrocare Technologies Ltd EPS calculated?

The EPS of Thyrocare Technologies Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Thyrocare Technologies Ltd report its EPS?

Thyrocare Technologies Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Thyrocare Technologies Ltd EPS?

Factors that influence the EPS of Thyrocare Technologies Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Thyrocare Technologies Ltd EPS growth indicate future performance?

Yes, consistent growth in Thyrocare Technologies Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*